Blackstone among suitors for Orchid Pharma; Greenko eyes Essel’s solar assets – VCCircle

Private equity giant Blackstone, drugmakers Strides Shasun and Nectar Lifesciences are ahead in the race to acquire debt-laden Orchid Pharma, The Economic Times reported citing two persons aware of the development. Dr.Reddys Laboratories and Aurobindo Pharma are no longer in contention for Orchid Pharma, the report said. Orchid Pharma is undergoing a corporate insolvency resolution…

Subcontractors stop work as major WA builder signals cashflow trouble – WAtoday

A West Australian builder with a long history of delivering major commercial projects has reportedly written to subcontractors warning them to down tools as the company reviews its “financial viability”. Cooper & Oxley is more than 60 years old and has delivered more than $2 billion in projects over the past decade, including the 1309 Hay Street Hotel Development, Baldivis Senior College…

Carillion: project companies should put contingency plans in place to deal with contractor liquidation, experts say – Out-Law.com

There are now over 700 operational PFI/PPP projects in England and Wales across all sectors, with a capital value of over £60 billion. More interestingly, over £200bn remains outstanding to be paid to the private sector for the provision of services over the remainder of the contract term, making the potential scale of the issue…